Recombinant CD274 (Atezolizumab Biosimilar) antibody

Catalog No. ABIN6964422

The Humanized Monoclonal anti-CD274 (Atezolizumab Biosimilar) antibody is suitable to detect CD274 (Atezolizumab Biosimilar) in samples from Human. It has been validated for FACS and ELISA.

Quick Overview for Recombinant CD274 (Atezolizumab Biosimilar) antibody (ABIN6964422)

Target: CD274 (Atezolizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD274 (Atezolizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA

Grade: Research Grade

Product Details anti-CD274 (Atezolizumab Biosimilar) Antibody

Purpose: Anti-PDL1 (atezolizumab biosimilar) mAb

Characteristics: MPDL3280A,RG7446

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CD274 (Atezolizumab Biosimilar)

Target: CD274 (Atezolizumab Biosimilar)

Alternative Name: PDL1 (Atezolizumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: PD-L1, CD274, B7-H1, PDCD1L1, PDCD1LG1

UniProt: Q9NZQ7